Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks edge up; Dechra surges on takeover offer

Fri, 14th Apr 2023 09:06

(Alliance News) - Stock prices in London opened in the green on Friday, following a rally on Wall Street as investors could see the end to the Federal Reserve's interest rate hiking cycle in sight.

The FTSE 100 index opened up 18.70 points, 0.2% at 7,862.08. The FTSE 250 was up 145.77 points, 0.8% at 19,215.90, and the AIM All-Share was up 3.91 points, 0.5%, at 828.71.

The midcap FTSE 250 index was outperforming, thanks to Dechra Pharmaceuticals, with the stock rising nearly 40% on a takeover offer late Thursday.

The Cboe UK 100 was up 0.2% at 786.07, the Cboe UK 250 was up 0.9% at 16,787.28, and the Cboe Small Companies was up 0.2% at 13,242.21.

In European equities, the CAC 40 in Paris was up 0.3%, while the DAX 40 in Frankfurt was 0.3%.

In the US on Thursday, Wall Street rallied, with the Dow Jones Industrial Average ending up 1.1%, the S&P 500 up 1.3% and the Nasdaq Composite up 2.0%.

Sentiment was buoyed by a cooler-than-expected wholesale inflation print.

According to the Department of Labor, producer price inflation eased to 2.7% year-on-year in March, from 4.9% in February, short of the FXStreet cited consensus of 3.4%. February's figure was upwardly revised from 4.5%.

This caused some to hope the Federal Reserve may be nearing the end of its rate hiking cycle.

"While the consensus remains that there is one more hike of 0.25% to come in May, there are no more rate rises expected thereafter this year," said interactive investor's Richard Hunter.

"Indeed, some are projecting that interest rate cuts could follow before the end of the year, depending on the severity of the recession which is expected to follow, although this is not currently the Fed’s base case," he added.

The dollar was mixed against major currencies, as the pound climbed higher above USD1.25, and the euro consolidated gains above USD1.10.

Sterling was quoted at USD1.2528 early Friday, higher than USD1.2519 at the London equities close on Thursday. The euro traded at USD1.1063 early Friday, higher than USD1.1053 late Thursday. Against the yen, the dollar was quoted at JPY132.58, up versus JPY132.41.

Later in the day, investors will hear from US banks, as Wells Fargo, JPMorgan and Citigroup report their quarterly earnings, along with asset manager BlackRock.

"The sector warrants particular attention given the recent banking turmoil, not least of which will be in terms of lending conditions, loan defaults, provisions for bad debts generally and the immediate outlook for the sector," said ii's Hunter.

Trading was upbeat in Asia on Friday, the Nikkei 225 index closed up 1.2%. In China, the Shanghai Composite added 0.6%, while the Hang Seng index in Hong Kong was up 0.2%. The S&P/ASX 200 in Sydney closed up 0.5%.

Brent oil stayed above the USD86 mark, trading at USD86.25 a barrel, down a touch from USD87.01 late Thursday. This followed the Organization of the Petroleum Exporting Countries warning of a "significant" shortfall of some 2 million barrels per day by the end of the year.

This will be a result of the production cut from major producers.

"The big question is what these higher prices will mean for consumers and inflation. The elevated levels raise concerns about how this will shake out for energy bills, food prices and monetary policy," said Sophie Lund-Yates, lead equity analyst at Hargreaves Lansdown.

Gold was quoted at USD2,040.26 an ounce early Friday, little changed from USD2,040.03 on Thursday.

In the FTSE 100, National Grid fell 1.2%, as it new UK tax measures for capital expenditure will weigh on earnings per share growth over the next few years.

The electricity infrastructure company said its annual performance was in line with its expectations. It continues to expect underlying earnings per share growth in the middle of its 6% to 8% compound annual growth rate. However, it warned that from financial 2024 to 2026, the UK government's introduction of 'full expensing' tax relief for capital expenditure will impact underlying EPS.

It now expects underlying EPS growth between financial 2022 to 2026 to be at the "lower end" of its 6-8% CAGR range.

In the FTSE 250, Dechra Pharmaceuticals surged 38% to 3,830 pence.

Late Thursday, the veterinary pharmaceutical company confirmed that it has entered into discussions with private equity firm EQT for a possible cash takeover offer.

Under the terms of the possible offer, Dechra shareholders would receive 4,070 pence per ordinary share in cash. The offer price is a 49% premium to Thursday's closing price.

"There can be no certainty that any firm offer will be made for Dechra," the company said.

Dr Martens fell 1.1% as it warned it will miss annual guidance slightly, thanks to weaker wholesale trade and costs from its LA distribution centre.

The bootmaker said that in the year to March 31, revenue was up 10%, with revenue in the fourth quarter up 6%. In January, it had guided for annual revenue growth of between 11% and 13%. During the final quarter, the firm noted strong direct-to-consumer trading led by retail growth, though this was partly offset by a weaker wholesale performance.

It now expects annual earnings before interest, tax, depreciation and amortisation of GBP245 million, below January's guidance of between GBP250 million and GBP260 million.

The miss is a result of higher-than-expected expenses related to solving operation issues at its LA distribution centre. Dr Martens maintains its guidance of mid-to-high single-digit revenue growth on a constant currency basis in financial 2024.

"The shares have fallen almost 70% since they listed in 2021, which was partly a function of a frothy valuation, but also raises questions about the long-term growth trajectory for the famous shoe brand," noted HL's Lund Yates.

Polling firm YouGov rose 1.7% as it appointed a former Meta Platforms executive as its new chief executive officer.

Steve Hatch, who served as Meta's vice president for Northern Europe, will join from August 1.

Last October, YouGov announced plans for its Founder & CEO Stephan Shakespeare to leave his role, and become non-executive chair from August 2023. He will replace current Chair Roger Parry.

Still to come in Friday's economic calendar, US retail sales are at 1330 BST, with US industrial production at 1500 BST.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
5 Sep 2022 09:23

TOP NEWS: Dechra shares down as post-pandemic growth rates slow

(Alliance News) - Dechra Pharmaceuticals PLC on Monday reported higher full-year profit and revenue, though it warned that growth rates are normalising as pandemic tailwinds ease.

Read more
5 Sep 2022 08:48

LONDON MARKET OPEN: Countryside and Vistry sign GBP1.3 billion merger

(Alliance News) - Stocks in London were under pressure at the opening bell on Monday, as the mood turned sour on Friday evening after Russia shut off access to a key gas pipeline.

Read more
5 Sep 2022 07:51

LONDON MARKET BRIEFING: Gazprom's move gets week off to bumpy start

(Alliance News) - Stocks in London are set to kick off the new week on the back foot, as Russia's move to stop gas deliveries to Europe is giving investors pause, amid growing fears of an energy crisis.

Read more
5 Sep 2022 07:01

Dechra Pharmaceuticals FY revenues and profits rise

(Sharecast News) - Veterinary pharmaceuticals group Dechra said on Monday that both revenues and profits had risen throughout the twelve months ended 30 June.

Read more
30 Aug 2022 17:04

LONDON MARKET CLOSE: Stocks move into reverse as pessimism takes over

(Alliance News) - Stocks in London returned from the long weekend on Tuesday to close in the red despite spending most of the session in the green, as investors wiped out the morning's gains following selling pressure in the US.

Read more
30 Aug 2022 12:16

LONDON MARKET MIDDAY: Pound weakness props up FTSE 100 as oil fades

(Alliance News) - The FTSE 100 remained in the green on Tuesday at midday on account of a weaker pound, but gains ebbed as oil prices retreated from morning highs.

Read more
30 Aug 2022 08:49

TOP NEWS: Dechra Pharmaceuticals buys US manufacturer Med-Pharmex

(Alliance News) - Dechra Pharmaceuticals PLC on Tuesday said it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex Inc for USD260.0 million.

Read more
30 Aug 2022 07:59

LONDON MARKET PRE-OPEN: Bunzl raises full-year margin outlook

(Alliance News) - Stock trading in London is set for a tepid start as UK market participants return from holiday on Tuesday, catching up with Monday's losses in Europe, as investors continue to mull over hawkish remarks from the head of the US central bank.

Read more
30 Aug 2022 07:53

Dechra Pharmaceuticals buys California-based Med-Pharmex for $260m

(Sharecast News) - Dechra Pharmaceuticals said on Tuesday that it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex for $260m (£221.5m).

Read more
21 Jul 2022 17:08

LONDON MARKET CLOSE: Stocks rise; ECB supersizes interest rate hike

(Alliance News) - Stocks in London ended higher on Thursday as investors digested another raft of corporate earnings, while the European Central Bank surprised markets with an aggressive rate hike.

Read more
21 Jul 2022 09:26

Dechra raises £180m in discounted placing for Piedmont deal

(Sharecast News) - Dechra Pharmaceuticals slumped on Thursday after the animal drug maker raised around £180m in a discounted share placing for the acquisition of US-based Piedmont Animal Health.

Read more
21 Jul 2022 09:03

LONDON MARKET OPEN: Large-caps down ahead of ECB; Russian gas resumes

(Alliance News) - Large-cap stocks in Europe struggled in early dealings on Thursday, as traders await a policy decision from the European Central Bank and after gas supplies through the critical Nord Stream pipeline restarted.

Read more
21 Jul 2022 08:47

Dechra Pharmaceuticals raises GBP184 million for acquisition pipeline

(Alliance News) - Veterinary products firm Dechra Pharmaceuticals PLC on Thursday said it raised GBP184 million in a discounted share placing and subscription for its acquisition pipeline.

Read more
20 Jul 2022 18:34

Dechra to raise GBP180 million to acquire Piedmont Animal Health

(Alliance News) - Veterinary products firm Dechra Pharmaceuticals PLC on Wednesday said it is planning a fundraise for an acquisition, as it progresses talks for another potential buy.

Read more
14 Jul 2022 08:29

IN BRIEF: Dechra diversifies funding with private placement notes

Dechra Pharmaceuticals PLC - veterinary products firm - Signs private placement of EUR50 million seven year and EUR100 million ten year senior unsecured notes. Weighted average coupon of the fixed rate notes will equate to 3.8%. Says issue has similar covenants to existing facilities. "The private placement is being undertaken now to achieve the group's aim of ensuring diversified sources of funding and to extend the group's debt maturity profile. All proceeds from the placement will be used to repay existing debt on the group's revolving credit facility." Dechra says.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.